Return to search results
Ethacrynate sodium
Ethacrynate Sodium is a prescription loop diuretic medication used to treat fluid retention (edema) by increasing urine production. It comes as a lyophilized powder for intravenous injection, with each vial containing 50 mg of the active ingredient. Manufactured by Leading Pharma, LLC, under application ANDA208663. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Ethacrynate Sodium is a prescription loop diuretic medication used to treat fluid retention (edema) by increasing urine production. It comes as a lyophilized powder for intravenous injection, with each vial containing 50 mg of the active ingredient. Manufactured by Leading Pharma, LLC, under application ANDA208663. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Ethacrynate sodium",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Ethacrynate sodium — ANDA 208663 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208663"
}
]
|
| identifier | ANDA208663 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"drug-safety",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Ethacrynate sodium |
